← Leaderboards
Robert Jon Soiffer
Dana-Farber Cancer Institute
$8,435,164
Attributed
$11,539,664
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$34,411,026 · 11
By mechanism
P01$17,423,093 · 6
U19$10,778,933 · 3
R01$6,209,000 · 2
Top collaborators
- Jerome Ritz10 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Stephanie J Lee$27,273,126
- Haesook Kim$5,471,874
- Eva C Guinan$4,120,977
- David B. Miklos$5,009,214
- Robert Soiffer$742,398
Others in their field
Top investigators on “Allogenic”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$40,815,122
- Marcel R M Van Den Brink · Sloan-Kettering Institute For Cancer Res$39,678,762
- Bruce R. Blazar · University Of Minnesota$37,193,531
- Megan Sykes · Columbia University Health Sciences$33,587,479
Research focus
AllogenicImmunologicsDesignCellsClinical TrialsLeadTransplantationImmunoregulationRegulatory T-LymphocyteRefractoryChronic Graft Versus Host DiseaseNeoplastic CellRelapseImmune ResponseB-LymphocytesVaccinationImmuneHematologic NeoplasmsClinical ResearchT-LymphocyteAntigensTumor ImmunityDoseSafety
Grant awards (39)
Immune Modulation After Allogeneic HCT$2,684,637
P01 · FY2023 · CA · contact PI
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT$604,938
P01 · FY2023 · CA · contact PI
Administrative Support$64,263
P01 · FY2023 · CA · contact PI
Immune Modulation After Allogeneic HCT$2,684,637
P01 · FY2022 · CA · contact PI
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT$600,510
P01 · FY2022 · CA · contact PI
Immune Modulation After Allogeneic HCT$200,000
P01 · FY2022 · CA · contact PI
Immune Modulation After Allogeneic HCT$200,000
P01 · FY2022 · CA · contact PI
Administrative Support$70,649
P01 · FY2022 · CA · contact PI
Immune Modulation After Allogeneic HCT$2,739,426
P01 · FY2021 · CA · contact PI
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT$612,765
P01 · FY2021 · CA · contact PI
Administrative Support$72,090
P01 · FY2021 · CA · contact PI
Immune Modulation After Allogeneic HCT$2,740,234
P01 · FY2020 · CA · contact PI
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT$612,765
P01 · FY2020 · CA · contact PI
Administrative Support$72,090
P01 · FY2020 · CA · contact PI
Immune Modulation After Allogeneic HCT$2,779,234
P01 · FY2019 · CA · contact PI
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT$612,765
P01 · FY2019 · CA · contact PI
Administrative Support$72,090
P01 · FY2019 · CA · contact PI
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000
R01 · FY2017 · CA · contact PI
Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000
R01 · FY2017 · CA
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000
R01 · FY2016 · CA · contact PI
Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000
R01 · FY2016 · CA
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000
R01 · FY2015 · CA · contact PI
Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000
R01 · FY2015 · CA
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$924,000
R01 · FY2014 · CA · contact PI
Reconstitution of Regulatory T Cells After Stem Cell Transplantation$485,000
R01 · FY2014 · CA
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation$700,000
R01 · FY2013 · CA · contact PI
Reconstitution of Regulatory T Cells After Stem Cell Transplantation$500,000
R01 · FY2013 · CA
Immune Modulation/Hematopoietic Cell Transplantation$799,185
U19 · FY2010 · AI · contact PI
Immune Modulation/Hematopoietic Cell Transplantation$1,883,752
U19 · FY2009 · AI · contact PI
Induction of Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplant$385,724
U19 · FY2009 · AI · contact PI
Immune Modulation/Hematopoietic Cell Transplantation$1,838,712
U19 · FY2008 · AI · contact PI
Induction of Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplant$377,051
U19 · FY2008 · AI · contact PI
Immune Modulation/Hematopoietic Cell Transplantation$1,829,756
U19 · FY2007 · AI · contact PI
Induction of Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplant$376,183
U19 · FY2007 · AI · contact PI
Immune Modulation/Hematopoietic Cell Transplantation$1,836,094
U19 · FY2006 · AI · contact PI
Induction of Anti-Tumor Immunity after HC Transplant$361,114
U19 · FY2006 · AI · contact PI
Immune Modulation/Hematopoietic Cell Transplantation$855,695
U19 · FY2005 · AI
Induction of Anti-Tumor Immunity after HC Transplant$172,096
U19 · FY2005 · AI
Administrative &Communications Core$63,571
U19 · FY2005 · AI